# Combination treatment with aripiprazole, haloperidol, and quetiapine in a case of treatment-resistant pyromania: a case report - URL: https://alisanburak.com/en/wcp-2026-posterler/ev1126 - Language: en - Last updated: not specified - Page title: Combination treatment with aripiprazole, haloperidol, and quetiapine in a case of treatment-resistant pyromania: a case report | WCP 2026 Summary > In a case of pyromania unresponsive to multiple treatment trials, fire-setting behavior ceased completely with a triple antipsychotic regimen consisting of que… This page was translated automatically from Turkish. [Read the original](https://alisanburak.com/wcp-2026-posterler/ev1126) This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it. EV1126 E-PosterPsychopharmacologyCase Report # Combination treatment with aripiprazole, haloperidol, and quetiapine in a case of treatment-resistant pyromania: a case report COMBINATION THERAPY WITH ARIPIPRAZOLE, HALOPERIDOL, AND QUETIAPINE IN A TREATMENT-REFRACTORY PATIENT WITH PYROMANIA: A CASE REPORT Presenter: Aikaterini Gamvroula Country: Greece Institution: General Hospital of Argolida, Department of Psychiatry In a case of pyromania unresponsive to multiple treatment trials, fire-setting behavior ceased completely with a triple antipsychotic regimen consisting of quetiapine, haloperidol, and aripiprazole. The aim of this report is to describe the pharmacological management of a treatment-resistant case of pyromania characterized by recurrent deliberate fire-setting, in which comorbid paraphilias reinforced the behavioral impulse. The patient is a 46-year-old woman with a history of multiple psychiatric admissions, 11 documented incidents of arson, and a co-occurring sexual paraphilia. Previous treatment trials included valproate as a mood stabilizer; fluoxetine, sertraline, venlafaxine, and vortioxetine from the SSRI/SNRI group; and risperidone, olanzapine, paliperidone, and zuclopenthixol as antipsychotics, but behavioral stability was not achieved. During her most recent admission, a triple antipsychotic regimen was initiated comprising quetiapine 300 mg (broad receptor profile), haloperidol 10 mg (potent D2 blockade), and aripiprazole 15 mg (D2 partial agonism). Long-term stability was achieved after discharge, with complete cessation of fire-setting tendencies and paraphilic urges, and no fire-setting behavior occurred after discharge (0 incidents). The authors suggest that multilevel modulation of dopaminergic and serotonergic pathways—namely, the combination of potent D2 blockade, stabilizing partial agonism, and a broad receptor profile—may have suppressed impulsivity and paraphilic arousal where conventional polypharmacy had failed. [View the original poster](https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1307) How to cite this study APA 7: Gamvroula, A., et al. (2026, September 23-26). Combination therapy with aripiprazole, haloperidol, and quetiapine in a treatment-refractory patient with pyromania: a case report [E-poster]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1307 Vancouver: Gamvroula A, et al. Combination therapy with aripiprazole, haloperidol, and quetiapine in a treatment-refractory patient with pyromania: a case report [e-poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1307 Author names and title formatting were generated automatically from the congress system; please check them against the original poster before use. ## On the same topic - [Açığı kapatmak: erişkin DEHB ilacı başlanmadan önce EKG sevk uyumunun iyileştirilmesi, kapalı döngü klinik denetim](https://alisanburak.com/en/wcp-2026-posterler/ev0088) - [Anksiyete bozukluğu olan hastalarda psikobiyotik müdahalesi: ısıl işlem görmüş Lactobacillus paracasei PS23'ün etkilerini inceleyen çift kör randomize kontrollü çalışma](https://alisanburak.com/en/wcp-2026-posterler/ev0126) - [Otizm spektrum bozukluğunda bumetanidin tedavi edici potansiyeli: güncel kanıtlar ve gelecek yönelimleri](https://alisanburak.com/en/wcp-2026-posterler/ev0157) - [Verbaskozid ile otizm spektrum bozukluğu tedavisinin mekanizmaları: ağ farmakolojisi, moleküler yerleştirme ve moleküler dinamik temelli inceleme](https://alisanburak.com/en/wcp-2026-posterler/ev0172) - [Otizm spektrum bozukluğunun çekirdek belirtilerinin tedavisinde kannabidiol: sistematik derleme](https://alisanburak.com/en/wcp-2026-posterler/ev0186) [All WCP 2026 summaries](https://alisanburak.com/en/wcp-2026-posterler) --- Kaynak / Source: https://alisanburak.com/en/wcp-2026-posterler/ev1126 İletişim / Contact: Bağdat Caddesi, Veli Güneysu Apt. No:453 K:4 D:9, Suadiye / Kadıköy, İstanbul · +90 532 642 95 25 · info@alisanburak.com · https://alisanburak.com/bagdat-caddesi-psikoterapi-iletisim